Instant Access! Watch Now
Check out Dr. Pimentel's new book, The Microbiome Connection, which is available through all major booksellers. If it's out of stock, grab the Kindle version.
Dr. Mark Pimentel is the top research doctor in the fields of IBS (Irritable Bowel Syndrome), SIBO (Small Intestine Bacterial Overgrowth), IMO (Intestinal Methanogen Overgrowth), and other functional gut disorders. He is in the process of mapping the microbiome of the small intestine and other major research breakthroughs to support both physicians and patients in resolving these complex conditions. He spends his days working tirelessly in the Pimentel Laboratory at Cedars-Sinai Medical Center in Los Angeles.
Instant Access! Watch Now
Check out Dr. Pimentel's new book, The Microbiome Connection, which is available through all major booksellers. If it's out of stock, grab the Kindle version.
Dr. Mark Pimentel is the top research doctor in the fields of IBS (Irritable Bowel Syndrome), SIBO (Small Intestine Bacterial Overgrowth), IMO (Intestinal Methanogen Overgrowth), and other functional gut disorders. He is in the process of mapping the microbiome of the small intestine and other major research breakthroughs to support both physicians and patients in resolving these complex conditions. He spends his days working tirelessly in the Pimentel Laboratory at Cedars-Sinai Medical Center in Los Angeles.
Instant Access! Watch Now
Steve Wright, co-founder of SCDLifestyle.com, is always full of practical, useful, action-oriented advice. He has been a pioneer in gut health education. His personal digestive health issues, IBS diagnosis, and his background as an engineer give him a unique perspective. He has literally helped millions heal their gut.
Instant Access! Watch Now
Steve Wright, co-founder of SCDLifestyle.com, is always full of practical, useful, action-oriented advice. He has been a pioneer in gut health education. His personal digestive health issues, IBS diagnosis, and his background as an engineer give him a unique perspective. He has literally helped millions heal their gut.
Instant Access! Watch Now
Watch all the conversations...
Since its inception in 2012, Microbiome Labs has valued education, collaboration, and research. To date, the company has attended, exhibited, and presented at more than 300 conferences; initiated and/or completed 14 clinical trials; and provided key solutions to thousands of practitioners, changing over 344,000 lives—and counting. Message us to see our research tables and studies we have completed… with many more to come!
Instant Access! Watch Now
Watch all the conversations...
Since its inception in 2012, Microbiome Labs has valued education, collaboration, and research. To date, the company has attended, exhibited, and presented at more than 300 conferences; initiated and/or completed 14 clinical trials; and provided key solutions to thousands of practitioners, changing over 344,000 lives—and counting. Message us to see our research tables and studies we have completed… with many more to come!
Instant Access! Watch Now
Satish S.C. Rao, MD, PhD, is an award-winning Professor of Medicine and Chief of the Division of Gastroenterology/Hepatology at the Digestive Health Center at Augusta University (Georgia). His research interests focus on the pathophysiology and treatment of inflammatory bowel disease, food intolerance (particularly fructose), constipation, fecal incontinence, and visceral pain, particularly esophageal chest pain. He has pioneered several new techniques of evaluating esophageal, gastric, colonic, and anorectal function, in particular the brain-gut axis, for which he has several patents, and he has pioneered technique of biofeedback therapy for dyssynergic defecation. He is currently investigating the neurobiologic mechanisms of biofeedback therapy and pioneering new treatments for fructose intolerance.
Instant Access! Watch Now
Satish S.C. Rao, MD, PhD, is an award-winning Professor of Medicine and Chief of the Division of Gastroenterology/Hepatology at the Digestive Health Center at Augusta University (Georgia). His research interests focus on the pathophysiology and treatment of inflammatory bowel disease, food intolerance (particularly fructose), constipation, fecal incontinence, and visceral pain, particularly esophageal chest pain. He has pioneered several new techniques of evaluating esophageal, gastric, colonic, and anorectal function, in particular the brain-gut axis, for which he has several patents, and he has pioneered technique of biofeedback therapy for dyssynergic defecation. He is currently investigating the neurobiologic mechanisms of biofeedback therapy and pioneering new treatments for fructose intolerance.